日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comparative Analysis of Pediatric and Adult Mastocytosis: Clinical Presentation, Triggers, and Treatment Patterns from a Tertiary Care Registry

儿童和成人肥大细胞增多症的比较分析：来自三级医疗机构登记的临床表现、诱发因素和治疗模式

期刊:Children-Basel
影响因子:2.1
doi:10.3390/children13010141
NoorSaeed, Sundus M; Khalaf, Roy; Alenezi, Athari; Fields, Eviatar; Prosty, Connor; Alrafiaah, Abdulaziz S; Miedzybrodzki, Barbara; Netchiporouk, Elena; Sampalis, John; Fein, Michael; Ben-Shoshan, Moshe
细胞生物学
肥大细胞
发表日期：2026
文献求助 收藏

Assessment of Quality of Life in Children with Chronic Urticaria Using the Children's Dermatology Life Quality Questionnaire Index: A Retrospective Cohort Study

利用儿童皮肤病生活质量问卷指数评估慢性荨麻疹患儿的生活质量：一项回顾性队列研究

期刊:International Archives of Allergy and Immunology
影响因子:1.8
doi:10.1159/000546466
Zhu, Catherine K; Benharira, Noha; Prosty, Connor; Gabrielli, Sofianne; Le, Michelle; Netchiporouk, Elena; Zhang, Xun; Fein, Michael N; Miedzybrodzki, Barbara; Ben-Shoshan, Moshe
麻疹
发表日期：2026
文献求助 收藏

A Comparison of Chronic Spontaneous Urticaria Clinical Characteristics and Management between Canadian and Israeli Adults

加拿大和以色列成年人慢性自发性荨麻疹临床特征和治疗的比较

期刊:International Archives of Allergy and Immunology
影响因子:1.8
doi:10.1159/000547551
Peri, Katya; Khalaf, Roy; Baum, Alona; Barzilai, Aviv; Netchiporouk, Elena; Fein, Michael Nathan; Ben-Shoshan, Moshe
麻疹
发表日期：2026
文献求助 收藏

Refractory erythroderma in idiopathic hypereosinophilic syndrome: A case treated with mepolizumab and abrocitinib

特发性嗜酸性粒细胞增多症合并难治性红皮病：一例采用美泊利单抗和阿布昔替尼治疗的病例

期刊:SAGE Open Medical Case Reports
影响因子:0.6
doi:10.1177/2050313X251400904
Elhaj, Hiba; Al Amari, Ahmad; Alyaqout, Fatemah; Ben-Shoshan, Moshe; Netchiporouk, Elena; Fein, Michael
细胞生物学
粒细胞
发表日期：2025
文献求助 收藏

Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization

mRNA COVID-19疫苗引起的过敏反应：既往脱敏后的随访和加强剂量

期刊:Frontiers in Allergy
影响因子:3.1
doi:10.3389/falgy.2023.1056619
AlOtaibi, Ibtihal; Almuhizi, Faisal; Ton-Leclerc, Shaonie; Fein, Michael; Tsoukas, Christos; Garvey, Lene Heise; Lee, Derek; Ben-Shoshan, Moshe; Isabwe, Ghislaine A C; Copaescu, Ana M
发表日期：2023
文献求助 收藏

Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series

对聚乙二醇过敏患者接种新冠疫苗的安全性：病例系列研究

期刊:Journal of Allergy and Clinical Immunology-In Practice
影响因子:6.6
doi:10.1016/j.jaip.2021.11.021
Picard, Matthieu; Drolet, Jean-Philippe; Masse, Marie-Soleil; Filion, Charles A; ALMuhizi, Faisal; Fein, Michael; Copaescu, Ana; Isabwe, Ghislaine Annie C; Blaquière, Martin; Primeau, Marie-Noël
微生物学
新冠
发表日期：2022
文献求助 收藏

Reply to "Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines"

回复“PEG过敏诱发阈值的差异限制了对含PEG mRNA COVID疫苗耐受性的预测”

期刊:Journal of Allergy and Clinical Immunology-In Practice
影响因子:6.6
doi:10.1016/j.jaip.2022.04.005
Picard, Matthieu; Drolet, Jean-Philippe; Masse, Marie-Soleil; Filion, Charles A; AlMuhizi, Faisal; Fein, Michael; Copaescu, Ana; Isabwe, Ghislaine Annie C; Blaquière, Martin; Primeau, Marie-Noël
发表日期：2022
文献求助 收藏

Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience.

对 2019 年冠状病毒病疫苗 (ARCOV) 的过敏反应研究：麦吉尔大学健康中心的经验

期刊:Annals of Allergy Asthma & Immunology
影响因子:4.7
doi:10.1016/j.anai.2022.05.014
ALMuhizi Faisal, Fein Michael, Gabrielli Sofianne, Gilbert Louise, Tsoukas Christos, Ben-Shoshan Moshe, Copaescu Ana M, Isabwe Ghislaine Annie Clarisse
心血管
发表日期：2022
文献求助 收藏

Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose.

对既往对第一剂疫苗有过敏反应史的患者进行mRNA COVID-19疫苗脱敏治疗的成功案例系列

期刊:Frontiers in Allergy
影响因子:3.1
doi:10.3389/falgy.2022.825164
AlMuhizi Faisal, Ton-Leclerc Shaonie, Fein Michael, Tsoukas Christos, Garvey Lene Heise, Lee Derek, Ben-Shoshan Moshe, Isabwe Ghislaine A C, Copaescu Ana M
发表日期：2022
文献求助 收藏

CSACI position statement: Newer generation H(1)-antihistamines are safer than first-generation H(1)-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria

CSACI立场声明：新一代H1受体拮抗剂比第一代H1受体拮抗剂更安全，应作为治疗过敏性鼻炎和荨麻疹的一线抗组胺药。

期刊:Allergy Asthma and Clinical Immunology
影响因子:2.4
doi:10.1186/s13223-019-0375-9
Fein, Michael N; Fischer, David A; O'Keefe, Andrew W; Sussman, Gord L
麻疹
信号转导
鼻炎
发表日期：2019
文献求助 收藏